Search
for
Sort by
Research 30 of 1000+
- Permanent Localized Hair Repigmentation Following Herpes Zoster Infection
- Herpes Zoster Development After Intraarticular Sodium Hyaluronate Injection
- 1389 Local injection with anti-herpes simplex virus antibodies protects against development of herpes simplex virus–induced sweating disturbance
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- [Mycophenolate mofetil in induction and maintenance therapy for juvenile onset severe lupus nephritis].
- Hair and Scalp Infections
- Keloids After Herpes Zoster: Report of Wolf’s Isotopic Phenomenon and Literature Review
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Herpes Zoster Precipitating First Attack of Neuromyelitis Optica along with Perinuclear Anti-Neutrophilic Cytoplasmic Antibody Positive Vasculitis
- Operational research on the correlation between skin diseases and HIV infection in Tigray region, Ethiopia
- Cutaneous Appendage Damage after Herpes Zoster
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Dermatological Issues Among Individuals Receiving Palliative Care - A Review
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- A clinical study of Geriatric dermatoses at Tertiary care center in South India
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- 512 Varicella-zoster virus in actively spreading segmental vitiligo skin
- Herpes zoster ophthalmicus (HZO) secondary to platelet-rich plasma (PRP) therapy - A case report
- Wolf’s Isotopic Response in a Post Herpes Zoster Patient Forming Superficial Basal Cell Carcinoma
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- Postherpetic Poliosis
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Shared Spaces: Decoding Dual Dermatoses in a Single Dermatome
- Dermatological manifestations associated with COVID‐19 and COVID‐19 vaccination: results from the Lebanese COVID registry
- Alopecia as a systemic disease
- Diagnosis of stress-associated dermatologic conditions in New York City safety-net hospitals during the COVID-19 pandemic
- Janus Kinase (JAK) Inhibitors in Dermatology: An Update and Critical Review